Nicotine Replacement Therapy Sampling for Smokers in the Community (QTW2023)

The University of Hong Kong (HKU)

Status: Enrolling

Conditions: Tobacco Smoking

Treatments: Behavioral: Brief cessation advice; Behavioral: 1-week nicotine replacement therapy sampling

Study type: Interventional

Funder types: Other

Identifiers

NCT05881083

QTW2023

Details and patient eligibility

About

The aim of this clinical trial is to test the effectiveness of 1-week nicotine replacement therapy sampling delivered by lay counsellors in promoting smoking cessation in smokers in the community.

Enrollment: 1,014 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Hong Kong residents aged 18 years or above
2. Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
3. Exhaled carbon monoxide level ≥4 part per million or a positive salivary cotinine test
4. Able to communicate in and read Chinese
5. Have a local contact number

Exclusion criteria

1. Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy
2. Pregnant or breastfeeding
3. Recent (≤ 2 weeks) angina, cardiac arrhythmia or heart attacks

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

1,014 participants in 2 patient groups

Intervention group

Experimental group

Description:

1-week nicotine replacement therapy sample + Brief cessation advice

Treatment:

Behavioral: 1-week nicotine replacement therapy sampling

Behavioral: Brief cessation advice

Control group

Active Comparator group

Description:

Brief cessation advice

Treatment:

Behavioral: Brief cessation advice